Biaryl guanidine inhibitors of in vitro HCV-IRES activity

Bioorganic and Medicinal Chemistry Letters

Volumn 14, Issue 20, 2004, Pages 5139-5143

  Jefferson, Elizabeth A ^a   Seth, Punit P ^a   Robinson, Dale E ^a   Winter, Dana K ^a   Miyaji, Alycia ^a   Osgood, Stephen A ^a   Swayze, Eric E ^a   Risen, Lisa M ^a  

^a ISIS PHARMACEUTICALS   (United States)

Author keywords

HCV; HCV IRES; Inhibitor; RNA

Indexed keywords

ANTIVIRUS AGENT; GUANIDINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG DETERMINATION; DRUG SYNTHESIS; HEPATITIS C VIRUS; IN VITRO STUDY; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; STRUCTURE ACTIVITY RELATION; TRANSLATION INITIATION;

ANTIVIRAL AGENTS; DATABASES, FACTUAL; GUANIDINES; HEPACIVIRUS; PROTEIN BIOSYNTHESIS; RIBOSOMES; STRUCTURE-ACTIVITY RELATIONSHIP; TRANSCRIPTION, GENETIC; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 4544388184     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2004.07.066     Document Type: Article

References (24)

1. A.M. Di Bisceglie Lancet 351 1998 351 355
2. Q.L. Choo, G. Kuo, A.J. Weiner, L.R. Overby, D.W. Bradley, and M. Houghton Science 244 1989 359 362
3. M. Berenguer, and T.L. Wright Antiviral Ther. 3 1998 125 136
4. A.M. Di Bisceglie, J. McHutchison, and C.M. Rice Hepatology 35 2002 224 231
5. S.-L. Tan, A. Pause, Y. Shi, and N. Sonenberg Nat. Rev. Drug Discovery 1 2002 867 881
6. J. Gallego, and G. Varani Biochem. Soc. Trans. 30 2002 140 146
7. M.E. Major, and S.M. Feinstone Hepatology 25 1997 1527 1538
8. R. Jubin Curr. Opin. Mol. Ther. 3 2001 278 287
9. H. Zhang, R. Hanecak, V. Brown-Driver, R. Azad, B. Conklin, M.C. Fox, and K.P. Anderson Antimicrob. Agents Chemother. 43 1999 347 353
10. K.J. Ryu, and S.W. Lee J. Biochem. Mol. Biol. 36 2003 538 544
11. W. Wang, P. Preville, N. Morin, S. Mounir, W. Cai, and M.A. Siddiqui Bioorg. Med. Chem. Lett. 10 2000 1151 1154
12. Ikeda, M. S.; Tsuai, I.; Zuao, I.; Ryan, H.; Iyan, S.; Kai, Y.; Kako, Y.; Tsukada, I.; Yanagisawa, M. JP8268890, 1996
13. Kai, Y. S.; Kaku, Y.; Tsukada, I.; Yanagisawa, M. JP7069899, 1996
14. M. Honda, S. Kaneko, E. Matsushita, K. Kobayashi, G.A. Abell, and S.M. Lemon Gastroenterology 118 2000 152 162
15. 50 values were determined from dose-response curves using 10 concentrations per compound. Reported values are the average of two-three determinations
16. S. Kim, and K.Y. Yi Tetrahedron Lett. 26 1985 1661 1664
17. M. Li, L.J. Wilson, and D.E. Portlock Tetrahedron Lett. 42 2001 2273 2275
18. L.H. Amundsen, and L.S. Nelson J. Am. Chem. Soc. 73 1951 242 244
19. Synthesis of compound 6: S.M. Hutchins, and K.T. Chapman Tetrahedron Lett. 35 1994 4055 4058
20. Synthesis of compound 7: L. Gomez, F. Gellibert, A. Wagner, and C. Mioskowski J. Comb. Chem. 2 2000 75 79
21. W. Wendelin, and A. Harler Monatsh. Chem. 106 1975 1479 1493
22. M.A. Maier, J.M. Leeds, G. Balow, R.H. Springer, R. Bharadwaj, and M. Manoharan Biochemistry 41 2002 1323 1327
23. P.G. Wyatt, R.C. Bethell, N. Cammack, D. Charon, N. Dodic, B. Dumaitre, D.N. Evans, D.V.S. Green, P.L. Hopewell, D.C. Humber, R.B. Lamont, D.C. Orr, S.J. Plested, D.M. Ryan, S.L. Sollis, R. Storer, and G.G. Weingarten J. Med. Chem. 38 1995 1657 1665
24. +)